{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T22:22:57Z","timestamp":1790374977586,"version":"4.1.0"},"reference-count":89,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32200522"],"award-info":[{"award-number":["32200522"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.phymed.2023.154968","type":"journal-article","created":{"date-parts":[[2023,7,22]],"date-time":"2023-07-22T03:05:03Z","timestamp":1689995103000},"page":"154968","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Blocking LTB4 signaling-mediated TAMs recruitment by Rhizoma Coptidis sensitizes lung cancer to immunotherapy"],"prefix":"10.1016","volume":"119","author":[{"given":"Jiangna","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinglin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruijie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunli","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phymed.2023.154968_bib0001","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.pharmthera.2016.03.001","article-title":"Phytomedicine polypharmacology: cancer therapy through modulating the tumor microenvironment and oxylipin dynamics","volume":"162","author":"Apaya","year":"2016","journal-title":"Pharmacol. Ther."},{"issue":"12","key":"10.1016\/j.phymed.2023.154968_bib0002","doi-asserted-by":"crossref","first-page":"3748","DOI":"10.1109\/TMI.2021.3097665","article-title":"Lung nodule malignancy prediction in sequential CT scans: summary of ISBI 2018 challenge","volume":"40","author":"Balagurunathan","year":"2021","journal-title":"IEEE Trans. Medical Imaging"},{"issue":"20","key":"10.1016\/j.phymed.2023.154968_bib0003","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1038\/sj.onc.1210939","article-title":"A key in vivo antitumor mechanism of action of natural product-based brassinins is inhibition of indoleamine 2, 3-dioxygenase","volume":"27","author":"Banerjee","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.phymed.2023.154968_bib0004","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/nrc3958","article-title":"The tumor microenvironment after radiotherapy: mechanisms of resistance and recurrence","volume":"15","author":"Barker","year":"2015","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.phymed.2023.154968_bib0005","article-title":"CD8 lymphocytes in tumors and nonsynonymous mutational load correlate with prognosis of bladder cancer patients treated with immune checkpoint inhibitors","volume":"1","author":"Boya","year":"2018","journal-title":"Cancer Rep."},{"issue":"8","key":"10.1016\/j.phymed.2023.154968_bib0006","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007244","article-title":"Macrophage-derived ltb4 promotes abscess formation and clearance of staphylococcus aureus skin infection in mice","volume":"14","author":"Brandt","year":"2018","journal-title":"PLOS Pathog."},{"key":"10.1016\/j.phymed.2023.154968_bib0007","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3389\/fcell.2018.00038","article-title":"Targeting tumor-associated macrophages as a potential strategy to enhance the response to immune checkpoint inhibitors","volume":"6","author":"Cassetta","year":"2018","journal-title":"Front. Cell Dev. Biol."},{"issue":"12","key":"10.1016\/j.phymed.2023.154968_bib0008","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/nrd.2018.169","article-title":"Targeting macrophages: therapeutic approaches in cancer","volume":"17","author":"Cassetta","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"issue":"11","key":"10.1016\/j.phymed.2023.154968_bib0009","doi-asserted-by":"crossref","first-page":"3401","DOI":"10.3390\/cancers12113401","article-title":"Targeting tumor-associated macrophages to increase the efficacy of immune checkpoint inhibitors: a glimpse into novel therapeutic approaches for metastatic melanoma","volume":"12","author":"Ceci","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.phymed.2023.154968_bib0010","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.biopha.2018.04.052","article-title":"Coptisine from rhizoma coptidis exerts an anti-cancer effect on hepatocellular carcinoma by up-regulating mir-122","volume":"103","author":"Chai","year":"2018","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.phymed.2023.154968_bib0011","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0092-8674(02)00801-2","article-title":"E2F4\/5 and p107 as Smad cofactors linking the TGF\u03b2 receptor to c-myc repression","volume":"110","author":"Chen","year":"2002","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.phymed.2023.154968_bib0012","first-page":"15","article-title":"Lung cancer risk in never-smokers: an overview of environmental and genetic factors","volume":"3","author":"Cheng","year":"2021","journal-title":"Chin. J. Cancer Res."},{"issue":"7","key":"10.1016\/j.phymed.2023.154968_bib0013","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.ccell.2021.05.006","article-title":"Tim-4\u00a0+\u00a0cavity-resident macrophages impair anti-tumor CD8\u00a0+\u00a0Tcell immunity","volume":"9","author":"Chow","year":"2021","journal-title":"Cancer Cell"},{"issue":"5","key":"10.1016\/j.phymed.2023.154968_bib0014","first-page":"1","article-title":"Systems pharmacology: a combination strategy for improving efficacy of PD-1\/PD-L1 blockade","volume":"22","author":"Chunli","year":"2021","journal-title":"Brief. Bioinform."},{"issue":"2","key":"10.1016\/j.phymed.2023.154968_bib0015","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/JLB.3MR0320-444R","article-title":"Natural products and their derivatives: promising modulators of tumor immunotherapy","volume":"108","author":"Deng","year":"2020","journal-title":"J. Leukoc. Biol."},{"issue":"9","key":"10.1016\/j.phymed.2023.154968_bib0016","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/s41419-020-02926-8","article-title":"M2 macrophage-induced lncRNA PCAT6 facilitates tumorigenesis and angiogenesis of triple-negative breast cancer through modulation of VEGFR2","volume":"11","author":"Dong","year":"2020","journal-title":"Cell Death Dis."},{"issue":"11","key":"10.1016\/j.phymed.2023.154968_bib0017","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/nri1961","article-title":"Interferons, immunity and cancer immunoediting","volume":"6","author":"Dunn","year":"2006","journal-title":"Nat. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.phymed.2023.154968_bib0018","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nrc3245","article-title":"The immune contexture in human tumors: impact on clinical outcome","volume":"12","author":"Fridman","year":"2012","journal-title":"Nat. Rev. Cancer"},{"issue":"4","key":"10.1016\/j.phymed.2023.154968_bib0019","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/j.1349-7006.2012.02212.x","article-title":"Antitumor effect of berberine against primary effusion lymphoma via inhibition of nf-\u03bab pathway","volume":"103","author":"Goto","year":"2012","journal-title":"Cancer Sci."},{"issue":"6","key":"10.1016\/j.phymed.2023.154968_bib0020","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.cell.2017.08.004","article-title":"NF-\u03baB c-Rel is crucial for the regulatory T cell immune checkpoint in cancer","volume":"170","author":"Grinberg-Bleyer","year":"2017","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.phymed.2023.154968_bib0021","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.phymed.2023.154968_bib0022","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"Gsva: gene set variation analysis for microarray and RNA-Seq data","volume":"14","author":"Hnzelmann","year":"2013","journal-title":"BMC Bioinf."},{"issue":"2","key":"10.1016\/j.phymed.2023.154968_bib0023","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.18632\/aging.202410","article-title":"Systems pharmacology dissection ofEpimediumtargeting tumor microenvironment to enhance cytotoxic T lymphocyte responses in lung cancer","volume":"13","author":"Huang","year":"2021","journal-title":"Aging"},{"issue":"5","key":"10.1016\/j.phymed.2023.154968_bib0024","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1093\/bib\/bbt035","article-title":"Systems pharmacology in drug discovery and therapeutic insight for herbal medicines","volume":"15","author":"Huang","year":"2014","journal-title":"Brief. Bioinform."},{"key":"10.1016\/j.phymed.2023.154968_bib0025","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.3389\/fphar.2020.01009","article-title":"Advances in molecular mechanisms for traditional chinese medicine actions in regulating tumor immune responses","volume":"11","author":"Huang","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phymed.2023.154968_bib0026","doi-asserted-by":"crossref","first-page":"38524","DOI":"10.1038\/srep38524","article-title":"Coptisine from Rhizoma coptidis suppresses hct-116 cells-related tumor growth in vitro and in vivo","volume":"7","author":"Huang","year":"2017","journal-title":"Sci. Rep."},{"issue":"38","key":"10.1016\/j.phymed.2023.154968_bib0027","doi-asserted-by":"crossref","first-page":"e22032","DOI":"10.1097\/MD.0000000000022032","article-title":"Large dosage Huangqin (Scutellaria) and Huanglian (Rhizoma Coptidis) for T2DM: a protocol of systematic review and meta-analysis of randomized clinical trials","volume":"99","author":"Huang","year":"2020","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10.1016\/j.phymed.2023.154968_bib0028","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0304-3835(00)00496-1","article-title":"Anticachectic effects of Coptidis rhizoma, an anti-inflammatory herb, on esophageal cancer cells that produce interleukin 6","volume":"158","author":"Iizuka","year":"2000","journal-title":"Cancer Lett."},{"issue":"11","key":"10.1016\/j.phymed.2023.154968_bib0029","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1002\/ptr.5693","article-title":"Berberis vulgaris and berberine: an update review","volume":"30","author":"Imenshahidi","year":"2016","journal-title":"Phytother. Res."},{"issue":"6","key":"10.1016\/j.phymed.2023.154968_bib0030","doi-asserted-by":"crossref","first-page":"e1792","DOI":"10.1038\/cddis.2015.162","article-title":"T-cell exhaustion in the tumor microenvironment","volume":"6","author":"Jiang","year":"2015","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.phymed.2023.154968_bib0031","first-page":"171","article-title":"Research progress in structural modification and pharmacological activities of berberine","volume":"32","author":"Jin","year":"2014","journal-title":"J. Pharm. Pract."},{"issue":"Apr.3 TN.6230","key":"10.1016\/j.phymed.2023.154968_bib0032","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1126\/science.aaa6204","article-title":"T cell exclusion, immune privilege, and the tumor microenvironment","volume":"348","author":"Joyce","year":"2015","journal-title":"Science"},{"issue":"7467","key":"10.1016\/j.phymed.2023.154968_bib0033","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nature12626","article-title":"Influence of tumor micro-environment heterogeneity on therapeutic response","volume":"501","author":"Junttila","year":"2013","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.phymed.2023.154968_bib0034","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/nar\/28.1.27","article-title":"Kegg: Kyoto encyclopedia of genes and genomes","volume":"28","author":"Kanehisa","year":"2000","journal-title":"Nucleic Acids Res."},{"issue":"9","key":"10.1016\/j.phymed.2023.154968_bib0035","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1158\/2326-6066.CIR-14-0156","article-title":"The coordinated actions of tim-3 on cancer and myeloid cells in the regulation of tumorigenicity and clinical prognosis in clear cell renal cell carcinomas","volume":"3","author":"Komohara","year":"2015","journal-title":"Cancer Immunol. Res."},{"issue":"3","key":"10.1016\/j.phymed.2023.154968_bib0036","doi-asserted-by":"crossref","first-page":"157","DOI":"10.28991\/esj-2019-01178","article-title":"Developing an integrated genomic profile for cancer patients with the use of NGS data","volume":"3","author":"Kosvyra","year":"2019","journal-title":"Emerg. Sci. J."},{"issue":"2","key":"10.1016\/j.phymed.2023.154968_bib0037","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0304-3835(95)03809-B","article-title":"Berberine complexes with DNA in the berberine-induced apoptosis in human leukemic HL-60 cells","volume":"93","author":"Kuo","year":"1995","journal-title":"Cancer Lett."},{"issue":"4","key":"10.1016\/j.phymed.2023.154968_bib0038","first-page":"286","article-title":"Prediction of human intestinal absorption based on molecular indices","volume":"23","author":"Lan-Ting","year":"2007","journal-title":"J. Mol."},{"issue":"4","key":"10.1016\/j.phymed.2023.154968_bib0039","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S2095-4964(17)60345-5","article-title":"Progress in research on the effects of traditional Chinese medicine on the tumor microenvironment","volume":"15","author":"Lin","year":"2017","journal-title":"J. Integr. Med."},{"issue":"1","key":"10.1016\/j.phymed.2023.154968_bib0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-019-0760-3","article-title":"Tumor-associated macrophages in tumor metastasis: biological roles and clinical therapeutic applications","volume":"12","author":"Lin","year":"2019","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.phymed.2023.154968_bib0041","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.3389\/fphar.2018.01473","article-title":"A novel systems pharmacology method to investigate molecular mechanisms of Scutellaria barbata D. Don for non-small cell lung cancer","volume":"9","author":"Liu","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"19","key":"10.1016\/j.phymed.2023.154968_bib0042","doi-asserted-by":"crossref","first-page":"13551","DOI":"10.1074\/jbc.M113.453811","article-title":"Cannabinoid receptor 2 suppresses leukocyte inflammatory migration by modulating the jnk\/c-jun\/alox5 pathway","volume":"288","author":"Liu","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.phymed.2023.154968_bib0043","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1016\/j.apsb.2020.06.014","article-title":"Berberine diminishes cancer cell pd-l1 expression and facilitates antitumor immunity via inhibiting the deubiquitination activity of csn5","volume":"10","author":"Liu","year":"2020","journal-title":"Acta Pharm. Sin."},{"issue":"1","key":"10.1016\/j.phymed.2023.154968_bib0044","doi-asserted-by":"crossref","first-page":"491","DOI":"10.3892\/mmr.2016.5285","article-title":"Palmatine from mahonia bealei attenuates gut tumorigenesis in apcmin\/+ mice via inhibition of inflammatory cytokines","volume":"14","author":"Ma","year":"2016","journal-title":"Mol. Med. Rep."},{"issue":"10","key":"10.1016\/j.phymed.2023.154968_bib0045","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2014.56.6018","article-title":"Five-year survival rates for treatment-naive patients with advanced melanoma who received ipilimumab plus dacarbazine in a phase iii trial","volume":"33","author":"Maio","year":"2015","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.phymed.2023.154968_bib0046","first-page":"603","article-title":"Local and systemic effects of an acute inflammation on eicosanoid generation capacity of polymorphonuclear cells and macrophages","volume":"71","author":"Mathieu","year":"1990","journal-title":"Int. J. Exp. Pathol."},{"issue":"5","key":"10.1016\/j.phymed.2023.154968_bib0047","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.4049\/jimmunol.142.5.1548","article-title":"Promotion of human t lymphocyte proliferation by il-4","volume":"142","author":"Mitchell","year":"1989","journal-title":"J. Immunol."},{"issue":"001","key":"10.1016\/j.phymed.2023.154968_bib0048","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41423-019-0306-1","article-title":"Myeloid immunosuppression and immune checkpoints in the tumor microenvironment","volume":"017","author":"Nakamura","year":"2020","journal-title":"Cell. Mol. Immunol."},{"issue":"11","key":"10.1016\/j.phymed.2023.154968_bib0049","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/nrclinonc.2017.88","article-title":"Monitoring immune-checkpoint blockade: response evaluation and biomarker development","volume":"14","author":"Nishino","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.phymed.2023.154968_bib0050","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.immuni.2014.06.010","article-title":"Tumor-associated macrophages: from mechanisms to therapy","volume":"41","author":"Noy","year":"2014","journal-title":"Immunity"},{"issue":"18","key":"10.1016\/j.phymed.2023.154968_bib0051","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1056\/NEJMra071371","article-title":"Leukotrienes","volume":"357","author":"Peters-Golden","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.phymed.2023.154968_bib0052","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.immuni.2016.06.001","article-title":"Resistance mechanisms to immune checkpoint blockade in cancer: tumor-intrinsic and -extrinsic factors","volume":"44","author":"Pitt","year":"2016","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.phymed.2023.154968_bib0053","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/nrc1256","article-title":"Tumor educated macrophages promote tumor progression and metastasis","volume":"4","author":"Pollard","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.phymed.2023.154968_bib0054","series-title":"Paper presented at the 2016 IEEE 1st International Conference on Power Electronics, Intelligent Control and Energy Systems (ICPEICES)","article-title":"Detection of Lung cancer cells using image processing techniques","author":"Pratap","year":"2016"},{"key":"10.1016\/j.phymed.2023.154968_bib0055","article-title":"Overcome cancer cell drug resistance using natural products","volume":"2015","author":"Pu","year":"2015","journal-title":"Evid. Based Complement. Alternat. Med."},{"issue":"1","key":"10.1016\/j.phymed.2023.154968_bib0056","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cell.2010.03.014","article-title":"Macrophage diversity enhances tumor progression and metastasis","volume":"141","author":"Qian","year":"2010","journal-title":"Cell"},{"issue":"19","key":"10.1016\/j.phymed.2023.154968_bib0057","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1056\/NEJMoa1606774","article-title":"Pembrolizumab versus chemotherapy for PD-L1-positive non-small-cell lung cancer","volume":"375","author":"Reck","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.phymed.2023.154968_bib0058","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.2353\/ajpath.2010.090879","article-title":"Tumor progression stage and anatomical site regulate tumor-associated macrophage and bone marrow derived monocyte polarization","volume":"176","author":"Redente","year":"2010","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.phymed.2023.154968_bib0059","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1096\/fba.2021-00066","article-title":"Neural regulations of the tumor microenvironment","volume":"4","author":"Restaino","year":"2021","journal-title":"FASEB bioAdv."},{"issue":"11","key":"10.1016\/j.phymed.2023.154968_bib0060","doi-asserted-by":"crossref","first-page":"4620","DOI":"10.1128\/iai.65.11.4620-4623.1997","article-title":"Chemokine secretion by human polymorphonuclear granulocytes after stimulation with mycobacterium tuberculosis and lipoarabinomannan","volume":"65","author":"Riedel","year":"1997","journal-title":"Infect. Immun."},{"key":"10.1016\/j.phymed.2023.154968_bib0061","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1056\/NEJMoa1503093","article-title":"Pembrolizumab versus ipilimumab in advanced melanoma","volume":"372","author":"Robert","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.phymed.2023.154968_bib0062","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1758-2946-6-13","article-title":"Tcmsp: a database of systems pharmacology for drug discovery from herbal medicines","volume":"6","author":"Ru","year":"2014","journal-title":"J. Cheminform."},{"issue":"11","key":"10.1016\/j.phymed.2023.154968_bib0063","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1002\/ptr.5669","article-title":"Natural products as mechanism based anticancer agents: Sp transcription factors as targets","volume":"30","author":"Safe","year":"2016","journal-title":"Phytother. Res."},{"issue":"5","key":"10.1016\/j.phymed.2023.154968_bib0064","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.2353\/ajpath.2010.090839","article-title":"The ltb4-blt1 axis mediates neutrophil infiltration and secondary injury in experimental spinal cord injury","volume":"176","author":"Saiwai","year":"2010","journal-title":"Am. J. Pathol."},{"issue":"4597","key":"10.1016\/j.phymed.2023.154968_bib0065","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1126\/science.6301011","article-title":"Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation","volume":"220","author":"Samuelsson","year":"1983","journal-title":"Science"},{"issue":"1\u20132","key":"10.1016\/j.phymed.2023.154968_bib0066","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s10787-006-1496-6","article-title":"The role of leukotrienes in the pathophysiology of inflammatory disorders: is there a case for revisiting leukotrienes as therapeutic targets?","volume":"14","author":"Sharma","year":"2006","journal-title":"Inflammopharmacology"},{"issue":"43","key":"10.1016\/j.phymed.2023.154968_bib0067","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"PNAS"},{"issue":"4","key":"10.1016\/j.phymed.2023.154968_bib0068","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.4049\/jimmunol.148.4.1143","article-title":"Il-10 inhibits human t cell proliferation and il-2 production","volume":"148","author":"Taga","year":"1992","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.phymed.2023.154968_bib0069","article-title":"Lipid mediators are critical in resolving inflammation: a review of the emerging roles of eicosanoids in diabetes mellitus","volume":"2015","author":"Tessaro","year":"2015","journal-title":"Biomed. Res. Int."},{"issue":"5","key":"10.1016\/j.phymed.2023.154968_bib0070","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ccr.2005.10.012","article-title":"TGF-\u03b2 directly targets cytotoxic T cell functions during tumor evasion of immune surveillance","volume":"8","author":"Thomas","year":"2005","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.phymed.2023.154968_bib0071","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2105-6-225","article-title":"Pathway level analysis of gene expression using singular value decomposition","volume":"6","author":"Tomfohr","year":"2005","journal-title":"BMC Bioinform."},{"issue":"7","key":"10.1016\/j.phymed.2023.154968_bib0072","doi-asserted-by":"crossref","first-page":"3810","DOI":"10.1073\/pnas.95.7.3810","article-title":"Cytokine-induced survival of activated t cells in vitro and in vivo","volume":"95","author":"Vella","year":"1998","journal-title":"PNAS"},{"issue":"21","key":"10.1016\/j.phymed.2023.154968_bib0073","first-page":"2018","article-title":"Pembrolizumab for the treatment of non-small-cell lung cancer","volume":"372","author":"Vozy","year":"2015","journal-title":"Oncologie."},{"issue":"27","key":"10.1016\/j.phymed.2023.154968_bib0074","doi-asserted-by":"crossref","first-page":"2002299","DOI":"10.1002\/adfm.202002299","article-title":"A combination of cowpea mosaic virus and immune checkpoint therapy synergistically improves therapeutic efficacy in three tumor models","volume":"30","author":"Wang","year":"2020","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.phymed.2023.154968_bib0075","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jep.2015.10.028","article-title":"Berberine and Coptidis Rhizoma as potential anticancer agents: recent updates and future perspectives","volume":"176","author":"Wang","year":"2015","journal-title":"J. Ethnopharmacol."},{"issue":"11","key":"10.1016\/j.phymed.2023.154968_bib0076","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1055\/s-0029-1185538","article-title":"In vivo inhibition of s180 tumors by the synergistic effect of the chinese medicina herbs coptis chinensis and evodia rutaecarpa","volume":"75","author":"Wang","year":"2009","journal-title":"Planta Med."},{"key":"10.1016\/j.phymed.2023.154968_bib0077","article-title":"Antitumor effects of immunity-enhancing traditional chinese medicine","volume":"121","author":"Wang","year":"2019","journal-title":"Biomed. Pharmacother."},{"issue":"18","key":"10.1016\/j.phymed.2023.154968_bib0078","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1091\/mbc.e14-04-0916","article-title":"How Taxol\/paclitaxel kills cancer cells","volume":"25","author":"Weaver","year":"2014","journal-title":"Mol. Biol. Cell."},{"issue":"1","key":"10.1016\/j.phymed.2023.154968_bib0079","first-page":"10","article-title":"Data mining analysis of professor Liu Shangyi's prescription characteristics in clinical medicine for the treatment of cancer patients with stomachache","volume":"3","author":"Wen-Qi","year":"2018","journal-title":"Tradit. Med. Res."},{"key":"10.1016\/j.phymed.2023.154968_bib0080","doi-asserted-by":"crossref","first-page":"25298","DOI":"10.1038\/srep25298","article-title":"Bufexamac ameliorates lps-induced acute lung injury in mice by targeting lta4h","volume":"6","author":"Xiao","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phymed.2023.154968_bib0081","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/1490738","article-title":"Synergistic effect and molecular mechanisms of traditional Chinese medicine on rvvegulating tumor microenvironment and cancer cells","volume":"2016","author":"Xu","year":"2016","journal-title":"BioMed. Res. Int."},{"issue":"6","key":"10.1016\/j.phymed.2023.154968_bib0082","doi-asserted-by":"crossref","first-page":"6964","DOI":"10.3390\/ijms13066964","article-title":"A novel chemometric method for the prediction of human oral bioavailability","volume":"13","author":"Xu","year":"2012","journal-title":"Int. J. Mol. Sci."},{"issue":"17","key":"10.1016\/j.phymed.2023.154968_bib0083","doi-asserted-by":"crossref","first-page":"3444","DOI":"10.1182\/blood-2011-10-383240","article-title":"Absence of LTB4\/BLT1 axis facilitates generation of mouse GM-CSF\u2013induced long-lasting antitumor immunologic memory by enhancing innate and adaptive immune systems","volume":"120","author":"Yokota","year":"2012","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.phymed.2023.154968_bib0084","doi-asserted-by":"crossref","first-page":"e37608","DOI":"10.1371\/journal.pone.0037608","article-title":"A systematic prediction of multiple drug-target interactions from chemical, genomic, and pharmacological data","volume":"7","author":"Yu","year":"2012","journal-title":"PLOS One"},{"key":"10.1016\/j.phymed.2023.154968_bib0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2020.153216","article-title":"Effect of epiberberine from Coptis chinensis Franch on inhibition of tumor growth in MKN-45 xenograft mice","volume":"76","author":"Yu","year":"2020","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phymed.2023.154968_bib0086","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.canlet.2019.05.017","article-title":"Targeting the tumor immune microenvironment for cancer therapy in human gastrointestinal malignancies","volume":"458","author":"Yza","year":"2019","journal-title":"Cancer Lett."},{"key":"10.1016\/j.phymed.2023.154968_bib0087","first-page":"11970","article-title":"Large-scale direct targeting for drug repositioning and discovery","volume":"5","author":"Zheng","year":"2015","journal-title":"Rep."},{"issue":"4","key":"10.1016\/j.phymed.2023.154968_bib0089","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/ijc.26094","article-title":"VEGF directly suppresses activation of T cells from ovarian cancer patients and healthy individuals via VEGF receptor Type 2","volume":"130","author":"Ziogas","year":"2012","journal-title":"Int. J. Cancer"},{"issue":"8","key":"10.1016\/j.phymed.2023.154968_bib0090","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.4161\/onci.21335","article-title":"Targeting PD-1\/PD-L1 interactions for cancer immunotherapy","volume":"1","author":"Zitvogel","year":"2012","journal-title":"Oncoimmunology"}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S094471132300329X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S094471132300329X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T18:49:15Z","timestamp":1760554155000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S094471132300329X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":89,"alternative-id":["S094471132300329X"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2023.154968","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Blocking LTB4 signaling-mediated TAMs recruitment by Rhizoma Coptidis sensitizes lung cancer to immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2023.154968","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"154968"}}